IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-319-09075-7_4.html
   My bibliography  Save this book chapter

Investment Considerations for Pharmaceutical Product Portfolios

In: Optimization of Pharmaceutical R&D Programs and Portfolios

Author

Listed:
  • Raymond A. Huml

    (Quintiles Transnational Corp.)

Abstract

Pharmaceutical executives with varying backgrounds and expertise are increasingly being asked to provide input on complex strategies related to portfolios of products, including regulatory and commercial competitive intelligence. Given the appropriate expertise – including preclinical, clinical pharmacology, clinical, regulatory affairs, CMC (Chemistry, Manufacturing and Controls)/supply chain, commercial, and patent law – they may be asked to help estimate the probabilities of achieving clinical milestones such as regulatory approval in a market of interest. They may also be asked to comment on product development even earlier in the development cycle, taking into account commercial insights, payer perspectives and quality-of-life issues. This chapter discusses investment decisions based on the author’s experience in investing in portfolios of pharmaceutical products, such as how much one can invest, and the palatability of the proposed return structure. The chapter breaks down many facets of this complex process to give insights into business decisions related to portfolios. Differences in portfolio strategy between big pharma and biotech companies are discussed, along with portfolio management, innovative partnering strategies and commercial perspectives

Suggested Citation

  • Raymond A. Huml, 2015. "Investment Considerations for Pharmaceutical Product Portfolios," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 49-69, Springer.
    • Handle: RePEc:spr:sprchp:978-3-319-09075-7_4
    DOI: 10.1007/978-3-319-09075-7_4
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-319-09075-7_4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.